Device Trial Radar · NCT03207685
Generalized Seizure Detection And Alerting In The EMU With The Empatica Embrace Watch And Smartphone-Based Alert System
Last checked: Nov 19, 2026Latest source record: Feb 2, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
100
Planned (sponsor's estimate)
Start
Jun 30, 2017
Primary completion
Jan 15, 2019
Study completion Jan 2022
Sponsor
- Lead sponsor
- Empatica, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jul 5, 2017
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Supportive care
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 1 month
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To demonstrate safety and effectiveness of the Embrace device in identifying convulsive seizures (CS) and notifying a caregiver during patient hospitalization at an epilepsy monitoring unit (EMU).
Conditions
- Epilepsy
Interventions
Additional Seizure MonitoringDevice
Embrace could offer an additional layer of seizure monitoring
Primary outcomes
What the sponsor says the trial is designed to measure.
- Comparison of Video-EEG to Embrace SystemTime frame: 6 months
Locations
2 sites in 2 countries. Site status is shown where the registry gives one.
NYU Langone Medical Center
New York, New York
Ospedale Pediatrico Bambino Gesù - Department of Neuroscience, Neurology Unit
Roma, Italy
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.